EMCOR Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EMCOR Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.99B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $14.57B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $12.58B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $11.08B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $9.90B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $8.80B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $9.17B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $8.13B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $7.69B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $7.55B | Feb 21, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.01B | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $1.89B | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $1.90B | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $1.89B | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $1.95B | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $1.92B | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $1.93B | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $1.74B | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $1.78B | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $1.70B | Feb 23, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.28B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.77B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.09B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.60B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.50B | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $383.85M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $363.18M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $315.29M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $333.06M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $364.75M | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.27B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.01B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $632.99M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $406.12M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $383.53M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $79.78M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $61.19M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | ($83.69M) | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $75.67M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $86.92M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $875.76M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $564.88M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $530.80M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $256.83M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $460.89M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $403.08M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $328.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $306.93M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.42B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.21B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.04B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $970.94M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $903.58M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $893.45M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $799.16M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $758.71M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $727.07M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $899.66M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $497.93M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $318.82M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $806.37M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $355.70M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $271.01M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $366.05M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $262.37M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.29B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $7.72B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $6.61B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.52B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $5.44B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $5.06B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.83B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $4.09B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $3.97B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $3.85B | Feb 21, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.62B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.14B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.55B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.19B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.01B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.77B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.35B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.29B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $2.31B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.67B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.94B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.47B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.97B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.25B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.05B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.06B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.74B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.67B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.54B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.41B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.02B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $956.55M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $919.15M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $890.27M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $851.78M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.06B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $990.89M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $964.89M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $979.63M | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.01B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.81B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.21B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.84B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.48B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.37B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.06B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.80B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.60B | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $789.75M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $456.44M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $821.35M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $902.87M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $358.82M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $363.91M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $467.43M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $464.62M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2012 | $0 | Feb 25, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 21 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 21 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44.52M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 45.81M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 47.05M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 47.67M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 53.30M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 54.76M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 56.22M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 55.98M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 58.80M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 59.95M | Feb 22, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $43.38M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $32.68M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $27.19M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $28.16M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $17.67M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $17.95M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $18.64M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $18.97M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $19.45M | Feb 21, 2019 |